α₁-Antichymotrypsin, Human Plasma

Acute-phase protein present at 45 mg/100 ml in plasma. Specific inhibitor of chymotrypsin-like serine proteinases.

Acute-phase protein present at ~45 mg/100 ml in plasma. Specific inhibitor of chymotrypsin-like serine proteinases. Molecular weight ranges from 65,000-68,000 daltons.

M.W. 65,000-68,000.

Cell permeable: no

Primary Target
Chymotrypsin-like serine proteases

Product does not compete with ATP.

Reversible: no

Toxicity: Standard Handling (A)

Lyophilized from 150 mM NaCl, 20 mM Tris-HCl, pH 7.4.

Please refer to vial label for lot-specific volume prior to lyophilization.

Prepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for at up to 6 months at -20°C.

Desrochers, P.E., et al. 1992. J. Biol. Chem.267, 5005.
Rayford, A., et al. 1992. J.Neurochem.58, 88.
Travis, J., et al. 1978. Biochemistry17, 5651.

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.